Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases.

Four commercial enzyme immunoassays (EIAs) for the detection of Clostridium difficile toxin A have recently been developed and marketed (Premier, Meridian Diagnostics, Cincinnati, Ohio; VIDAS, bioMerierux Vitek, Inc., Hazelwood, Mo.; Tox-A-Test, TechLab, Blacksburg, Va.; and Bartels, Baxter Diagnost...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Microbiol
Autors principals:	Whittier, S, Shapiro, D S, Kelly, W F, Walden, T P, Wait, K J, McMillon, L T, Gilligan, P H
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1993
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC266145/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8263168/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.31.11.2861-2865.1993
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!